Pneumomediastinum following intubation in COVID-19 patients: a case series.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 32375200.
- Also identified by DOI 10.1111/anae.15113 and PMC identifier 7267505.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The number of patients requiring tracheal intubation rose dramatically in March and April 2020 with the COVID-19 outbreak. Our thoracic surgery department has seen an increased incidence of severe pneumomediastinum referred for surgical opinion in intubated patients with COVID-19 pneumonitis. Here we present a series of five patients with severe pneumomediastinum requiring decompression therapy over a 7-day period in the current COVID-19 outbreak. We hypothesise that the mechanism for this is the aggressive disease pathophysiology with an increased risk of alveolar damage and tracheobronchial injury, along with the use of larger-bore tracheal tubes and higher ventilation pressures. We present this case series in order to highlight the increased risk of this potentially life-threatening complication among the COVID-19 patient cohort and offer guidance for its management to critical care physicians.
Medical subject headings
- Betacoronavirus
- Coronavirus Infections
- Intubation, Intratracheal
- Mediastinal Emphysema
- Pneumonia, Viral